Top compounds associated with response to IRX4


Feature Type Standardized
Nominal ANOVA
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.022 0.5
mRNA Axitinib GDSC1000 pan-cancer AAC 0.025 0.5
mRNA PLX4720 CTRPv2 pan-cancer AAC -0.024 0.5
mRNA CAL-101 GDSC1000 pan-cancer AAC -0.022 0.5
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.024 0.5
mRNA AT7867 CTRPv2 pan-cancer AAC -0.023 0.5
mRNA CP466722 GDSC1000 pan-cancer AAC 0.02 0.5
mRNA FMK GDSC1000 pan-cancer AAC 0.025 0.5
mRNA Bosutinib FIMM pan-cancer AAC 0.25 0.5
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.024 0.5
Download CSV